RHO and retinal degeneration: Treatment with flavonoids in vitro positively modulated the stability of ligand-free RHO, and in vivo delayed retinal degeneration by reducing UPR and oxidative stress in mouse models bearing the P23H RHO mutation (Ortega et al., 2019, 2022).